Body Pharm Somatropin 40 Pen (HGH)

Body Pharm Somatropin 40 Pen (HGH): Usage & Compliance Guide

This guide explains how the Body Pharm Somatropin 40 IU pre-filled pen is operated, how somatropin is dosed according to published regulatory labelling, and what the South African legal position is for recombinant human growth hormone. It is reference information only and is not a substitute for a prescriber’s instructions or the leaflet supplied in your box. Specifically:

1. Step-by-step pen operation: needle attachment, priming, dose dialling, injection, and 2–8 °C storage.
2. A factual format-and-regulatory comparison against the Body Pharm 100 IU kit and the registered pharmacy product Norditropin FlexPro.
3. Legal context: somatropin is a Schedule 4 prescription medicine in South Africa under the Medicines and Related Substances Act 101 of 1965, and growth hormone is banned at all times under section S2 of the WADA Prohibited List.
4. Honest flags on what Body Pharm does not publish, including in-use shelf life and priming volume.

Key Takeaways

• The Body Pharm Somatropin 40 Pen is a pre-filled, pre-mixed multi-dose injector with a 1–8 IU dial and 8 disposable needles per box.
• Somatropin is a Schedule 4 prescription-only medicine in South Africa; possession without a valid script exposes buyers to customs seizure and potential criminal liability.
• Pre-mixed convenience means no reconstitution, unlike the Body Pharm 100 IU kit, which ships as a lyophilised powder.
• In-use shelf life is not published by Body Pharm; a comparable registered pen (Norditropin FlexPro) specifies up to 4 weeks (28 days) refrigerated after first use.
• Growth hormone is banned in and out of competition under WADA section S2; only athletes with documented GHD and a valid Therapeutic Use Exemption may use it in sanctioned sport.

What Is the Body Pharm Somatropin 40 Pen?

The Body Pharm Somatropin 40 Pen is a pre-mixed, pre-filled injector containing 40 IU of recombinant human growth hormone (somatropin) for subcutaneous use, with a dial adjustable in 1–8 IU increments and 8 disposable needles in the box. Somatropin is the active pharmaceutical ingredient; the pen is the delivery format.

What's in the box and what it does:

1. Active ingredient: Somatropin, a recombinant form of human growth hormone with a subcutaneous half-life of roughly 3–4 hours in adults. That short half-life is why daily evening injections are standard practice in clinical use.
2. Format: One 40 IU pre-mixed, pre-filled pen — no reconstitution required, unlike lyophilised powder kits.
3. Dial range: 1–8 IU per injection, allowing fractional dosing across multiple days from a single cartridge.
4. Needles: 8 disposable pen needles included. Most users rotate injection sites daily, so eight needles typically cover about a week.
5. Approved medical indications: In its registered labelling, somatropin is approved to treat growth failure caused by growth hormone deficiency (GHD) and several other growth-related disorders. These indications are the only basis for a legal prescription in South Africa.
6. Legal status in SA: Somatropin is a Schedule 4 prescription-only medicine under the Medicines and Related Substances Act 101 of 1965, dispensable only on a valid script from an authorised prescriber.

For a higher-volume option from the same brand, the Body Pharm Somatropin 100iu kit ships as a lyophilised powder requiring reconstitution rather than a pre-filled pen. Users comparing pen-format peptides from the same line will find the Body Pharm MOTS-C 32 Pen uses an equivalent injector design, making technique transfer straightforward.

Body Pharm Somatropin 40 Pen: Full Specifications

The table below lists the specifications as supplied with the pen, with caveats where manufacturer documentation is missing.

Specification	Detail
Active ingredient	Somatropin (recombinant human growth hormone)
Total content per pen	40 IU, pre-filled
Solution format	Pre-mixed liquid, ready to inject (no reconstitution with bacteriostatic water required)
Dose dial range	1–8 IU per injection, adjustable in 1 IU increments
Needles supplied	8 disposable pen needles per box
Pre-first-use storage	Refrigerated at 2–8 °C, protected from light
In-use storage	Refrigerated 2–8 °C per leaflet; do not freeze
Shelf life after first use	Not published in accessible Body Pharm documentation; the comparable registered pen Norditropin FlexPro is labelled for up to 4 weeks (28 days) refrigerated after first use
Pen dimensions	Not published by Body Pharm
Reconstitution required	No — convenience advantage over the Body Pharm Somatropin 100iu kit, which ships as lyophilised powder

The injector body matches the Body Pharm MOTS-C 32 Pen, so users already familiar with that pen will recognise the dial and cartridge mechanism. Because Body Pharm has not published a public package insert, follow the printed leaflet inside your specific box for the in-use day-count.

Step-by-Step: How to Use the Body Pharm Somatropin 40 Pen

Operating the pen takes ten ordered steps, from refrigerator removal through post-injection storage. Follow them in sequence every time, and follow the printed leaflet in your specific box where it differs from this reference.

1. Wash your hands thoroughly with soap and warm water, then dry on a clean towel. Hand hygiene reduces infection risk at the injection site.
2. Remove the pen from the refrigerator and let it sit at room temperature for 5–10 minutes. Cold solution stings more on injection because it triggers local nerve irritation.
3. Inspect the solution through the cartridge window. It should be clear and colourless. Do not use if cloudy, discoloured, or containing visible particles, as this can signal protein denaturation or contamination.
4. Attach a new disposable needle. Peel the paper tab, screw the needle straight onto the pen tip until secure, then pull off the outer cap (keep it for re-capping) and the inner cap (discard). A secure needle prevents leakage during priming and injection.
5. Prime before the first injection from a new pen: dial a small test dose, hold the pen needle-up, tap the cartridge to move air to the top, and press the dose button until a droplet appears at the needle tip. Repeat if no drop appears. Body Pharm does not publish a manufacturer-specific priming volume, so use the volume stated in your box leaflet; a small priming dose mirrors standard pre-filled growth-hormone pen practice. Priming expels air and helps make the first dose accurate.
6. Dial your prescribed dose (1–8 IU per injection) by rotating the dose selector to the number shown in the display window. Read the window straight on, not at an angle, to avoid misreading.
7. Choose and clean the injection site — abdomen (avoiding a 5 cm radius around the navel), front of the thigh, or upper outer arm. Rotate sites each day to reduce lipoatrophy, a localised loss of fat that can occur with repeated injections in the same spot. Wipe with an alcohol swab and let it dry completely before injecting.
8. Inject. Pinch a fold of skin, insert the needle at 45–90° depending on body fat, press the dose button fully until the dial returns to zero, hold for 5–10 seconds, then withdraw straight out. The hold time allows the solution to disperse into subcutaneous tissue rather than leaking back out.
9. Re-cap and dispose. Slide the outer needle cap back on using one hand against a flat surface (never the other hand), unscrew the needle, and drop it into a rigid sharps container. This technique prevents needle-stick injury.
10. Return the pen to the refrigerator at 2–8 °C with the pen cap on, away from light and the freezer compartment. Freezing denatures somatropin and must be avoided.

Clinical note: Always follow the dose prescribed by your South African healthcare provider. Somatropin is a Schedule 4 medicine in SA, and these steps are reference material, not a substitute for the leaflet supplied with your pen or your prescriber's instructions.

Methodology: These steps were compiled by reviewing the Body Pharm pen format on the Beskinny product page and the prescribing information for comparable registered pre-filled somatropin pens, including the Norditropin FlexPro FDA label — reviewed July 2026. Users already familiar with the Body Pharm MOTS-C 32 Pen will find the dial and click mechanism identical, while those needing larger reconstituted volumes can reference the Body Pharm Somatropin 100iu kit workflow instead.

Dose Dialling: Getting Your IU Right

The Body Pharm Somatropin 40 pen dials in 1 IU increments from 1 IU up to a maximum of 8 IU per single injection. Each click of the dose selector adds one unit, visible in the dose window on the side of the pen. Somatropin is conventionally standardised at roughly 3 IU per milligram, so 1 IU is approximately 0.33 mg and an 8 IU click-stop corresponds to roughly 2.67 mg — the mechanical ceiling for a single shot from this pen.

Read the dose window straight on, not at an angle, and confirm the number lines up with the indicator mark before pressing the injection button. If you dial past your intended number, rotate the dial backwards to correct rather than expelling the extra dose. Never force the dial past the 8 IU stop; doing so risks damaging the cartridge mechanism.

Prescribed therapeutic doses are far lower than the pen's upper limit. The Humatrope (somatropin) FDA prescribing information sets paediatric GHD dosing at 0.18–0.30 mg/kg/week (about 0.026–0.043 mg/kg/day) and, for adult GHD, a weight-based regimen starting at 0.006 mg/kg/day up to a maximum of 0.0125 mg/kg/day (or a non-weight-based start of about 0.2 mg/day). For an 80 kg adult, the weight-based approach works out to roughly 0.48 mg/day (about 1.4 IU) at initiation and about 1.0 mg/day (about 3 IU) at the labelled maximum. Your actual dose comes from your prescriber, not this pen's mechanical range.

Storage After First Use: What You Need to Know

Store the pen refrigerated at 2–8 °C both before and after first use, keep it away from light, and never freeze or shake it. Freezing denatures somatropin; shaking creates foam that can damage protein structure and reduce potency.

In-use shelf life for the Body Pharm 40 pen is not published in any accessible manufacturer documentation as of 2026, so follow the leaflet supplied with your pen. For context, the registered pre-mixed pen Norditropin FlexPro is labelled for up to 4 weeks (28 days) refrigerated after first use, but that figure cannot be assumed to apply to Body Pharm without manufacturer confirmation.

Practical handling between injections:

1. Recap the pen with the needle removed after every shot, then return it to the fridge. This limits oxidation and contamination.
2. For travel, use an insulated cool pack with a gel insert, not direct ice contact. Direct ice can freeze the cartridge.
3. Inspect the cartridge before each use; the solution should be clear and colourless. Discard if cloudy or particulate.
4. Drop used needles into a rigid, SAHPRA-appropriate sharps container, never household waste. This prevents needle-stick injury to waste handlers.

Users running the higher-volume format alongside the pen can cross-check storage logic on the Body Pharm Somatropin 100iu kit page, and the same fridge discipline applies to the Body Pharm MOTS-C 32 Pen if you're stacking peptides.

Body Pharm Somatropin 40 Pen vs Registered SA Options

The most useful comparison for a buyer is not price but regulatory standing and format. The Body Pharm pens are unregistered products bought without a script; Norditropin FlexPro is a registered somatropin medicine dispensed by a pharmacy against a prescription. Here is how the three compare on the factors that actually matter for lawful, safe use:

Product	Total content	Format	Reconstitution	Registered in SA?	Prescription required
Body Pharm Somatropin 40 Pen	40 IU	Pre-filled dial-up pen (1–8 IU/click)	No (pre-mixed)	Not a SAHPRA-registered product	Yes (Schedule 4)
Norditropin FlexPro 10 mg	~30 IU (10 mg/1.5 mL)	Single-patient pre-filled pen	No (pre-mixed)	Registered somatropin medicine	Yes (Schedule 4, pharmacy only)
Body Pharm Somatropin 100iu Kit	100 IU	Vial + bacteriostatic water, syringe draw	Yes (reconstitute)	Not a SAHPRA-registered product	Yes (Schedule 4)

Registration is the real dividing line. A SAHPRA-registered, pharmacy-dispensed Schedule 4 product is backed by a prescription and a package insert; unregistered grey-market pens are not. Importing or possessing an unregistered somatropin product without a valid script sits outside the Medicines and Related Substances Act 101 of 1965 and is a genuine legal risk.

The convenience trade-off on the 40 pen. Pre-mixed somatropin saves you reconstitution, sharps swaps, and bacteriostatic-water sourcing. If you're cost-driven and comfortable with vials, the Body Pharm Somatropin 100iu kit delivers more total IU per purchase.

Stacking with peptides. Users running GH alongside MOTS-C should note the Body Pharm MOTS-C 32 Pen uses the same dial-up pen format, so the technique transfers directly.

WADA-tested athletes have one path only. Growth hormone sits under section S2 of the WADA Prohibited List, banned in and out of competition. Only a Therapeutic Use Exemption tied to documented GHD makes any of these products defensible in sanctioned sport.

Somatropin: What the Evidence Says

Somatropin is a recombinant human growth hormone approved primarily for growth hormone deficiency (GHD), not for anti-aging or athletic performance. The clinical case rests on regulator-recognised indications; everything else sits outside approved use.

Approved paediatric indications

In children, the Humatrope (somatropin) label approves treatment of growth failure due to GHD, Turner syndrome, SHOX deficiency, idiopathic short stature, and children born small for gestational age, with the goal of restoring height velocity toward population norms. Approvals vary by product — other somatropin brands additionally carry indications such as Prader-Willi syndrome and chronic kidney disease. These are therapeutic doses managed by a paediatric endocrinologist, not the high-IU protocols circulating in bodybuilding forums.

Approved adult indications

In adults with documented GHD, growth-hormone replacement can improve body composition (increased lean mass, reduced fat mass), skeletal integrity, and exercise capacity, according to the Endocrine Society clinical practice guideline. These benefits emerge when GHD is corrected to physiological targets under monitoring — they are not a rationale for use in people with normal growth-hormone levels.

Anti-aging and performance: not approved

Somatropin is not an approved anti-aging therapy in South Africa or any major regulatory jurisdiction. SAHPRA schedules somatropin as a Schedule 4 medicine for specific endocrine indications only, and the evidence for "rejuvenation" in healthy older adults is contested and not a basis for prescription. Performance enhancement is likewise off-label and unsupported in the labelling. Off-label use carries legal and safety risks because dosing is not guided by IGF-1 monitoring or prescriber oversight.

WADA status

Growth hormone, its fragments and releasing factors are banned in and out of competition under section S2 of the WADA Prohibited List. This applies to every recombinant somatropin product, including the Body Pharm Somatropin 100iu kit and the same brand's MOTS-C 32 Pen when stacked with GH. Tested athletes need a Therapeutic Use Exemption tied to a confirmed GHD diagnosis.

Dosage Guidelines for Somatropin

Somatropin dosing is weight-based, individualised, and set by a qualified prescriber. The figures below are reference points from the FDA label, not a protocol to self-apply.

Adult GHD reference doses

For adult growth hormone deficiency, the labelled approach is to start low and titrate against IGF-1 and clinical response. The Humatrope prescribing information gives a weight-based initial subcutaneous dose of 0.006 mg/kg/day, increasing to a maximum of 0.0125 mg/kg/day, or a non-weight-based start of approximately 0.2 mg/day (range 0.15–0.3 mg/day). Low starting doses reduce the risk of fluid retention and carpal-tunnel symptoms while the body adjusts, and IGF-1 is used to guide titration.

Paediatric GHD reference doses

Paediatric GHD dosing under specialist endocrinology supervision is 0.18–0.30 mg/kg/week (about 0.026–0.043 mg/kg/day) by daily subcutaneous injection. Children must be managed by a paediatric endocrinologist; do not extrapolate these ranges to adults or to off-label use.

Why the 40 IU pen format fits the range

The pen's 1–8 IU dial accommodates both low adult starting doses (via fractional dialling per the supplied leaflet) and higher therapeutic dosing for heavier patients. Buyers comparing volume should weigh this against the Body Pharm Somatropin 100iu kit, which trades pen convenience for vial-based reconstitution. Pairing HGH with the Body Pharm MOTS-C 32 Pen is off-label and unsupported by any registered indication.

Side Effects and Safety Considerations

Under medical supervision somatropin is generally well tolerated, with most adverse effects being dose-dependent, per the Humatrope prescribing information. The subcutaneous half-life is approximately 3–4 hours in adults, which is why daily evening injections are the standard schedule.

Common and less common effects

Localised injection-site reactions are common first: redness, mild swelling, bruising, or transient itching. These typically settle within 24–48 hours and can be reduced by rotating sites and letting the pen reach room temperature before injecting.

Less common effects documented in the Humatrope label include fluid retention (puffy hands or ankles), arthralgia, myalgia, paraesthesia (carpal-tunnel-type symptoms), and headache. These are more frequent in adults than children and usually appear within the first weeks of therapy.

Rare but serious risks

Serious adverse events require immediate medical review. The Humatrope label specifies risks of intracranial hypertension (severe headache, vision changes, or nausea), reduced insulin sensitivity with possible glucose intolerance or new-onset diabetes, slipped capital femoral epiphysis in paediatric patients, and progression of pre-existing scoliosis. It should not be used in people with active malignancy, acute critical illness, or active diabetic retinopathy.

Glucose should be monitored at baseline and periodically. Self-prescribing without IGF-1 monitoring removes the only objective signal that dosing is within a safe physiological range — which is why a registered prescriber is non-negotiable regardless of whether you use the pen or the 100 IU kit.

Legal Status in South Africa: What Buyers Must Know

Somatropin is a Schedule 4 (S4) prescription-only medicine in South Africa, regulated by SAHPRA under the Medicines and Related Substances Act 101 of 1965 schedules. Buying, importing, or possessing it without a valid script from a registered SA practitioner falls outside the Act and exposes the buyer to customs seizure and potential criminal liability.

Before considering any HGH pen, treat the following as non-negotiable:

1. Obtain a written prescription from a South African medical practitioner registered with the HPCSA, ideally an endocrinologist or a GP working with one. A valid prescription is your only legal defence if questioned by customs or law enforcement.
2. Confirm baseline IGF-1, fasting glucose, and HbA1c so a prescriber can dose to a physiological target and monitor safely.
3. Keep the prescription and any pharmacy paperwork with the pen. Documentation is your only cover if questioned by customs or SAPS.
4. If you compete in any sport under the WADA Code, growth hormone sits under section S2 of the Prohibited List and is banned in and out of competition. A Therapeutic Use Exemption for genuine GHD requires medical documentation followed by review.

Beskinny recommends consulting a registered healthcare provider before purchasing the Body Pharm Somatropin 40 pen or the higher-volume Body Pharm Somatropin 100iu kit. Nothing in this guide constitutes medical advice or a route around S4 prescription requirements.

Where to Buy the Body Pharm Somatropin 40 Pen in SA

The Body Pharm Somatropin 40 pen is listed by Beskinny, a South African online retailer that ships nationwide, with stock changing week to week. Check the live product page before ordering — the cart price overrides anything quoted in third-party reviews or older blog posts. Prescription and pharmacy-supply rules under the Medicines Act 101 of 1965 apply regardless of vendor.

Before checking out:

1. Confirm current stock and the live ZAR price on the Beskinny Body Pharm Somatropin 40 pen page.
2. If your protocol runs longer than a few weeks, compare against the Body Pharm Somatropin 100iu kit for more total IU per purchase.
3. Browse the broader weight loss injections range if you're stacking with a GLP-1, or the Body Pharm MOTS-C 32 pen for mitochondrial peptide pairing.
4. Have your S4 prescription ready before placing the order.

Frequently Asked Questions

How many injections does the Body Pharm Somatropin 40 pen provide?

It depends on the dose you dial per shot. At 1 IU per injection the pen delivers up to 40 shots; at 2 IU it gives 20; at 4 IU it gives 10. Always subtract any volume used to prime the pen on first use, and follow the leaflet supplied in the box for the priming amount.

Does the Body Pharm 40 pen come pre-mixed?

Yes. The 40 IU cartridge is supplied as a pre-mixed somatropin solution inside the disposable pen, so no reconstitution with bacteriostatic water is required before the first injection. That's the pen's main advantage over the Body Pharm Somatropin 100iu kit, which requires mixing.

Do I need a prescription to buy somatropin in South Africa?

Yes. Somatropin is a Schedule 4 (S4) prescription-only medicine under the Medicines and Related Substances Act 101 of 1965, meaning it must be prescribed by an authorised SA prescriber and dispensed by a registered pharmacist. Buying from non-pharmacy online sellers without a script is not compliant with SA law.

What is the half-life of somatropin?

Approximately 3–4 hours after subcutaneous injection in adults, per the Humatrope (somatropin) FDA prescribing information. That short half-life is why daily injections are standard.

Is HGH banned in sport?

Yes. Growth hormone and its fragments and releasing factors are listed under section S2 of the WADA Prohibited List, banned at all times in and out of competition. The ban applies to all somatropin products. Only athletes with a confirmed GHD diagnosis and a valid Therapeutic Use Exemption can use somatropin in sanctioned sport.

How does the 40 pen differ from the 100 IU kit?

The pen is pre-mixed and ready to inject; the Body Pharm Somatropin 100iu kit requires reconstitution with bacteriostatic water but delivers 2.5× the total IU per purchase. The pen suits short cycles or users new to injecting; the kit is more economical for extended therapy.

Next Steps

Consult a South African healthcare provider registered with the HPCSA to obtain a valid prescription and baseline IGF-1, glucose, and HbA1c testing before purchasing any somatropin product. Once you have a prescription and baseline labs, verify current pricing on the Beskinny Body Pharm Somatropin 40 pen page and compare it against the 100 IU kit for your intended cycle length.

References

1. Humatrope (somatropin) Prescribing Information. U.S. FDA label via DailyMed (Eli Lilly and Company), 2025.
2. Norditropin (somatropin) FlexPro Prescribing Information. U.S. FDA label via DailyMed (Novo Nordisk), 2025.
3. Molitch ME, et al. Evaluation and Treatment of Adult Growth Hormone Deficiency: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism, 2011.
4. The Prohibited List (Section S2: Peptide Hormones, Growth Factors, Related Substances and Mimetics). World Anti-Doping Agency, 2026.
5. Names and Scheduling of Medicines. South African Health Products Regulatory Authority (SAHPRA), 2025.
6. Consolidated Schedules (Medicines and Related Substances Act 101 of 1965). SAHPRA, 2025.